大葉大學圖書館 |

Molecular oncology testing for solid tumors[electronic resource] :a pragmatic approach /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.994075
書名/作者:	Molecular oncology testing for solid tumors : a pragmatic approach // edited by Michael Ola Idowu, Catherine Isabelle Dumur, Carleton Theodore Garrett.
其他作者:	Garrett, Carleton Theodore.
出版者:	Cham : : Springer International Publishing :, 2015.
面頁冊數:	ix, 742 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Cancer - Molecular diagnosis.
標題:	Cancer - Molecular aspects.
標題:	Medicine & Public Health.
標題:	Pathology.
標題:	Oncology.
ISBN:	9783319163048
ISBN:	9783319163031
內容註:	Part I. Overview of Basic Cellular Biology -- 1. Normal molecular biology and definition of terms -- 2. Pathologic changes: Chromosomes, genes, DNA, RNA and proteins -- 3. Standard nomenclature - introduction and brief overview -- Part II. Molecular Oncology Methodology -- 4. General principles of Oncology testing -- 5. Molecular methodologies -- 6. General principles of validating a molecular test -- Part III. Molecular testing in Solid Tumors -- 7. Lung and mediastinum -- 8. Breast -- 9. Head and neck (salivary glands) -- 10. Thyroid and parathyroid (endocrine) -- 11. Gastrointestinal and Pancreatobiliary -- 12. Soft tissue -- 13. Genitourinary system -- 14. Central Nervous System -- 15. Skin and adnexa -- 16. Common Hereditary Cancer Syndromes -- Part IV. The future is here -- 17. Application of next generation sequencing -- Part V. Quality Assurance and Regulatory affairs -- 18. Quality Assurance - pre-analytic, analytic and post-analytic -- 19. Regulatory affairs (including accreditation) -- 20. Coding and re-imbursement.
摘要、提要註:	This text is designed to present an up-to-date practical approach to molecular testing in an easy to understand format. Emphasis is placed on molecular testing for solid tumors, while underscoring the following: i) the crucial role of pathologists in ensuring specimen adequacy for molecular testing; ii) current molecular assays/platforms (including next-generation sequencing); iii) clinical utility and limitations of biomarkers to enable effective communication with clinicians; iv) the importance of quality assurance metrics to ensure accurate and reproducible results; v) pitfalls in test interpretation (that may lead to False Positive or False Negative interpretations); vi) importance of using standard nomenclature, including exercises on variant (mutation) description; vii) regulatory affairs, coding and reimbursement. The uniqueness of this text is the use of a standardized template for each of the molecular tests being discussed followed by a discussion of relevant quality assurance issues to ensure focused and efficient presentation of information. Molecular Oncology Testing for Solid Tumors will enable readers to easily understand the Ordering, Processing, Interpretation, Reporting and the clinical Application (OPIRA) process of molecular testing or biomarkers.
電子資源:	http://dx.doi.org/10.1007/978-3-319-16304-8

Molecular oncology testing for solid tumors[electronic resource] :a pragmatic approach /
Molecular oncology testing for solid tumorsa pragmatic approach /[electronic resource] :edited by Michael Ola Idowu, Catherine Isabelle Dumur, Carleton Theodore Garrett. - Cham :Springer International Publishing :2015. - ix, 742 p. :ill. (some col.), digital ;24 cm.

Part I. Overview of Basic Cellular Biology -- 1. Normal molecular biology and definition of terms -- 2. Pathologic changes: Chromosomes, genes, DNA, RNA and proteins -- 3. Standard nomenclature - introduction and brief overview -- Part II. Molecular Oncology Methodology -- 4. General principles of Oncology testing -- 5. Molecular methodologies -- 6. General principles of validating a molecular test -- Part III. Molecular testing in Solid Tumors -- 7. Lung and mediastinum -- 8. Breast -- 9. Head and neck (salivary glands) -- 10. Thyroid and parathyroid (endocrine) -- 11. Gastrointestinal and Pancreatobiliary -- 12. Soft tissue -- 13. Genitourinary system -- 14. Central Nervous System -- 15. Skin and adnexa -- 16. Common Hereditary Cancer Syndromes -- Part IV. The future is here -- 17. Application of next generation sequencing -- Part V. Quality Assurance and Regulatory affairs -- 18. Quality Assurance - pre-analytic, analytic and post-analytic -- 19. Regulatory affairs (including accreditation) -- 20. Coding and re-imbursement.

This text is designed to present an up-to-date practical approach to molecular testing in an easy to understand format. Emphasis is placed on molecular testing for solid tumors, while underscoring the following: i) the crucial role of pathologists in ensuring specimen adequacy for molecular testing; ii) current molecular assays/platforms (including next-generation sequencing); iii) clinical utility and limitations of biomarkers to enable effective communication with clinicians; iv) the importance of quality assurance metrics to ensure accurate and reproducible results; v) pitfalls in test interpretation (that may lead to False Positive or False Negative interpretations); vi) importance of using standard nomenclature, including exercises on variant (mutation) description; vii) regulatory affairs, coding and reimbursement. The uniqueness of this text is the use of a standardized template for each of the molecular tests being discussed followed by a discussion of relevant quality assurance issues to ensure focused and efficient presentation of information. Molecular Oncology Testing for Solid Tumors will enable readers to easily understand the Ordering, Processing, Interpretation, Reporting and the clinical Application (OPIRA) process of molecular testing or biomarkers.

ISBN: 9783319163048

Standard No.: 10.1007/978-3-319-16304-8doiSubjects--Topical Terms:

488784
Cancer
--Molecular diagnosis.

LC Class. No.: RC270

Dewey Class. No.: 616.994075

Molecular oncology testing for solid tumors[electronic resource] :a pragmatic approach /
LDR:03333nam a2200313 a 4500 001 443544
003 DE-He213
005 20160304142344.0
006 m d
007 cr nn 008maaau
008 160715s2015 gw s 0 eng d
020 $a 9783319163048 $q (electronic bk.)
020 $a 9783319163031 $q (paper)
024 7 $a 10.1007/978-3-319-16304-8 $2 doi
035 $a 978-3-319-16304-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270
072 7 $a MMF $2 bicssc
072 7 $a MED067000 $2 bisacsh
082 0 4 $a 616.994075 $2 23
090 $a RC270 $b .M718 2015
245 0 0 $a Molecular oncology testing for solid tumors $h [electronic resource] : $b a pragmatic approach / $c edited by Michael Ola Idowu, Catherine Isabelle Dumur, Carleton Theodore Garrett.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a ix, 742 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part I. Overview of Basic Cellular Biology -- 1. Normal molecular biology and definition of terms -- 2. Pathologic changes: Chromosomes, genes, DNA, RNA and proteins -- 3. Standard nomenclature - introduction and brief overview -- Part II. Molecular Oncology Methodology -- 4. General principles of Oncology testing -- 5. Molecular methodologies -- 6. General principles of validating a molecular test -- Part III. Molecular testing in Solid Tumors -- 7. Lung and mediastinum -- 8. Breast -- 9. Head and neck (salivary glands) -- 10. Thyroid and parathyroid (endocrine) -- 11. Gastrointestinal and Pancreatobiliary -- 12. Soft tissue -- 13. Genitourinary system -- 14. Central Nervous System -- 15. Skin and adnexa -- 16. Common Hereditary Cancer Syndromes -- Part IV. The future is here -- 17. Application of next generation sequencing -- Part V. Quality Assurance and Regulatory affairs -- 18. Quality Assurance - pre-analytic, analytic and post-analytic -- 19. Regulatory affairs (including accreditation) -- 20. Coding and re-imbursement.
520 $a This text is designed to present an up-to-date practical approach to molecular testing in an easy to understand format. Emphasis is placed on molecular testing for solid tumors, while underscoring the following: i) the crucial role of pathologists in ensuring specimen adequacy for molecular testing; ii) current molecular assays/platforms (including next-generation sequencing); iii) clinical utility and limitations of biomarkers to enable effective communication with clinicians; iv) the importance of quality assurance metrics to ensure accurate and reproducible results; v) pitfalls in test interpretation (that may lead to False Positive or False Negative interpretations); vi) importance of using standard nomenclature, including exercises on variant (mutation) description; vii) regulatory affairs, coding and reimbursement. The uniqueness of this text is the use of a standardized template for each of the molecular tests being discussed followed by a discussion of relevant quality assurance issues to ensure focused and efficient presentation of information. Molecular Oncology Testing for Solid Tumors will enable readers to easily understand the Ordering, Processing, Interpretation, Reporting and the clinical Application (OPIRA) process of molecular testing or biomarkers.
650 0 $a Cancer $x Molecular diagnosis. $3 488784
650 0 $a Cancer $x Molecular aspects. $3 336981
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Pathology. $3 340546
650 2 4 $a Oncology. $3 205017
700 1 $a Garrett, Carleton Theodore. $3 634277
700 1 $a Idowu, Michael Ola. $3 634275
700 1 $a Dumur, Catherine Isabelle. $3 634276
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-16304-8
950 $a Medicine (Springer-11650)